Recent Updates
Recently added Catalysts
BVS Positive Sentiment Score: 75/100

Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Key Takeaway: Bioventus Inc. announced that its CEO, Rob Claypoole, will present at the upcoming 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025. The presentation will be available via live webcast on the company's website and can be accessed until February 15, 2025. Bioventus, known for its innovative healing solutions, aims to assist patients in their recovery and active lifestyles, demonstrating its commitment to quality healthcare.

Market Sentiment Analysis

POSITIVE FACTORS

  • Bioventus CEO will present at a prominent healthcare conference.
  • The webcast will be accessible for an extended period, increasing engagement.
  • Bioventus emphasizes its commitment to high standards and evidence-based medicine.

Full Press Release Details

DURHAM, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, chief executive officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 10:30 a.m. PT (1:30 p.m. ET).
The live webcast of the presentation, including Q&A, may be accessed on the Investors section of the Bioventus website and will be available until February 15, 2025.
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.
Investor and Media Inquiries:

Frequently Asked Questions

When is Bioventus presenting at the J.P. Morgan Conference?

Bioventus will present on January 15, 2025, at 10:30 a.m. PT.

How can I access the Bioventus conference presentation?

The presentation can be accessed on the Investors section of Bioventus' website.

What are Bioventus' primary product focuses?

Bioventus focuses on Pain Treatments, Restorative Therapies, and Surgical Solutions.

What is Bioventus' mission?

Bioventus aims to help patients resume and enjoy active lives.

How long will the webcast of the presentation be available?

The webcast will be available until February 15, 2025.

Last updated: Jan 7, 2025